SCHEMBL3043839

SCHEMBL3043839

COc1cc(-c2cc3cc(Br)ccc3[nH]2)c2c(c1OS(C)(=O)=O)CNC2=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 10/20 0.46
AURKA O14965 9/20 0.46
CDK1 P06493 2/20 0.39
NQO2 P16083 1/20 0.39
GSK3B P49841 2/20 0.37
CCNB2 O95067 1/20 0.37
CCNB1 P14635 1/20 0.37
CDK5 Q00535 1/20 0.37
CDK5R1 Q15078 1/20 0.37
CCNB3 Q8WWL7 1/20 0.37
PARP1 P09874 1/20 0.36
EGFR P00533 1/20 0.35
ERBB2 P04626 1/20 0.35
IGF1R P08069 1/20 0.35
PDGFRB P09619 1/20 0.35
KIT P10721 1/20 0.35
PDGFRA P16234 1/20 0.35
FLT1 P17948 1/20 0.35
FLT4 P35916 1/20 0.35
TEK Q02763 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3047326 0.89 AURKA (0.53) KDRAURKACDK1NQO2CDK5
SCHEMBL3038071 0.89 AURKA (0.46) KDRAURKACDK1NQO2KDM4E
Hydrochloric Acid SCHEMBL3048315 0.88 AURKA (0.45) KDRAURKACDK1NQO2KDM4E
Hydrochloric Acid SCHEMBL3047981 0.87 KDR (0.50) KDRAURKACDK1NQO2EGFR
SCHEMBL3052415 0.86 KDR (0.43) KDRAURKACDK1NQO2PARP1
Hydrochloric Acid SCHEMBL3042483 0.85 AURKA (0.43) KDRAURKACDK1NQO2PARP1
SCHEMBL3045069 0.85 AURKA (0.42) KDRAURKACDK1NQO2PARP1
SCHEMBL3046942 0.85 AURKA (0.44) KDRAURKACDK1NQO2KDM4E
SCHEMBL3054784 0.85 AURKA (0.42) KDRAURKACDK1NQO2PARP1
Hydrochloric Acid SCHEMBL3049923 0.84 AURKA (0.42) KDRAURKACDK1NQO2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 KDR 3226/4885AURKA 2312/4885CDK1 922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.